News

June 8, 2023

The George Washington University School of Medicine and Health Sciences faculty promotion and/or tenure list and the members of the Class of 2023 Emeriti Faculty.

May 30, 2023

2023 GW School of Medicine and Health Sciences Diploma Ceremony Coverage

May 30, 2023

The George Washington University (GW) School of Medicine and Health Sciences Physical Therapy honors the Class of 2023 at annual awards ceremony.

May 30, 2023

The George Washington University (GW) School of Medicine and Health Sciences Physician Assistant Studies Program hosts annual awards program for the Class of 2023.

May 26, 2023

The George Washington University (GW) School of Medicine and Health Sciences (SMHS) Department of Obstetrics and Gynecology hosted the 86th annual Kane King Dodek Obstetrical Honor Society annual awards ceremony.

May 26, 2023

The George Washington University School of Medicine and Health Sciences celebrated the achievement of the Health Sciences Program Class of 2023, 391 members strong, representing 27 disciplines offered by GW.

May 26, 2023

The George Washington University MD Program Class of 2023 celebrates annual hooding and diploma ceremony featuring an address by Edward Barksdale Jr., MD, the Robert J. Izant Jr., MD, Professor and Surgeon-in-Chief at Rainbow Babies and Children’s Hospital/University Hospitals and Case Western…

May 26, 2023

The George Washington University School of Medicine and Health Sciences welcomed the newest members of the Alpha Chapter of the Alpha Omega Alpha Medical Honor Society, and hosted Carolyn Sufrin, MD, PhD, as the 15th Annual AΩA Visiting Professor.

May 16, 2023

The George Washington University (GW) School of Medicine and Health Sciences (SMHS) is pleased to announce that Stephanie Sarandos, MA, has been selected to serve as the assistant dean for evaluation. In this role, Sarandos will be responsible for all aspects of MD program evaluation, ensuring…

May 16, 2023

Pfizer has launched a Phase 3 study of its RSV vaccine candidate and researchers at the George Washington University are studying the vaccine’s safety and ability to trigger an immune response in two groups of people at risk for severe illness caused by respiratory syncytial virus or RSV.